Lisinopril Impurity 14 | CAS 488760-32-3 - Request Quote
Lisinopril Impurity 14
| SZ CAT No: | SZ-L027037 |
| CAS No | 488760-32-3 |
| Mol.F. | C20H33F3N2O5 |
| Mol.Wt. | 438.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lisinopril Impurity 14 is chemically N2-((S)-4-Cyclohexyl-1-ethoxy-1-oxobutan-2-yl)-N6-(2,2,2-trifluoroacetyl)-L-lysine. Lisinopril Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Lisinopril Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lisinopril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 488760-32-3
Purchase 488760-32-3
Order 488760-32-3
Enquire 488760-32-3
price of 488760-32-3
488760-32-3 Supplier
488760-32-3 Manufacturer
488760-32-3 Exporter
buy high quality Lisinopril Impurity 14
Purchase Lisinopril Impurity 14
Lisinopril Impurity 14 suppliers
Lisinopril Impurity 14 manufacturers
Lisinopril Impurity 14 price
Order Lisinopril Impurity 14
Enquire Lisinopril Impurity 14
Lisinopril Impurity 14 cost
Lisinopril Impurity 14 Supplier
Lisinopril Impurity 14 Distributor
Lisinopril Impurity 14 for Method Validation
Lisinopril Reference Standard
Lisinopril Impurity 14 for ANDA Filing
Lisinopril Impurity 14 for Forced Degradation Studies
Lisinopril Impurity 14 Identification Standards
Lisinopril Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


